Mykola Kushnir

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

G. Lip, A. Goette, M. Ezekowitz, 2016, The Lancet.

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

G. Lip, A. Goette, M. Ezekowitz, 2016, The Lancet.